Key Takeaways The S&P 500 gained 0.2% on Tuesday, Feb. 18, 2025, posting a record close to kick off an abbreviated trading ...

Some middle managers at Ford Motor will not get stock bonuses this year in what is seen internally as CEO Jim Farley's latest ...

Shares of Walgreens Boots Alliance (NASDAQ: WBA) were moving higher today after CNBC's David Faber said that a possible deal ...

As per a media report in December, Walgreens Boots Alliance Inc WBA +13.9% + Free Alerts suggested the company is in talks to ...

With underlying earnings growth of 7%, chemist owner and supplier EBOS Group is tapping healthy conditions in the sector.

However, the shift of strategic direction to wellness has raised uncertainty over Kirin’s long-term growth prospects, where execution plays a key role in integrating the acquired subsidiary and ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Self-developed PharmAID Decision Intelligence Platform Integrates Global Leading Large Model Technology and Has connected with Deepseek R1 As a pioneer in the AI transformation of the pharmaceutical ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Jenburkt Pharmaceuticals Limited, a 40-year-old pharmaceutical organization listed on the Bombay Stock Exchange and a pioneer in pain management, announced an unprecedented, first-time-ever ...